INICIO

Continuation of the Revista Mexicana de Cardiología

    
  • Home
  • Instructions for authors
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

Management of high blood pressure during all-trimesters of pregnancy

Múnera-Echeverri, Ana G; Ruiz-Gastelum, Edith

ABSTRACT

High blood pressure (HBP) disorders of pregnancy are one of the leading causes of morbidity during pregnancy along with maternal-fetal mortality in developing countries. In this work, we discuss the physiopathology, diagnostic assessment, and treatment and prevention strategies focused on diminishing the burden of hypertensive disorders of pregnancy at all-care levels. Most of the current guidelines encourage to perform an adequate assessment in every woman living with chronic HBP prior to pregnancy. Preeclampsia stands for a multisystemic, multifactorial, dynamic, and progressive disease that could appear at any gestation week. Furthermore, an adequate assessment of any hypertensive disorder of pregnancy is needed to prevent acute and long-term complications related these diseases. Pharmacological management should be based on clinical manifestations at the moment of evaluation. All woman with hypertensive disorder during pregnancy had an increased cardiovascular risk, therefore, continuous follow-up management is highly recommended.
  FULL TEXT PDF  

Keywords

High blood pressure pregnancy cardiovascular risk




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Impact of alternative therapies in the treatment of resistant systemic arterial...
    2022, Vol.33, Núm. S3
  • Implementation and barriers of high blood pressure guidelines and standards
    2022, Vol.33, Núm. S3
  • Systemic high blood pressure associated with psychosocial factors in Mexico: a...
    2022, Vol.33, Núm. S3
  • Measurement of systemic arterial blood pressure
    2022, Vol.33, Núm. S3
  • High blood pressure: the ambushed raider. Introductory remarks
    2022, Vol.33, Núm. S3
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2


Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: EN TRÁMITE. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 4 de abril de 2022.

 

2022     |     https://www.cardiovascularandmetabolicscience.org.mx/